Page last updated: 2024-08-23

colforsin and afimoxifene

colforsin has been researched along with afimoxifene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pasqualini, JR; Sumida, C1
Byrne, IM; Flanagan, L; Tenniswood, MP; Welsh, J1
Ford, BM; Franks, LN; Prather, PL; Radominska-Pandya, A1

Other Studies

3 other study(ies) available for colforsin and afimoxifene

ArticleYear
Stimulation of progesterone receptors by phorbol ester and cyclic AMP in fetal uterine cells in culture.
    Molecular and cellular endocrinology, 1990, Mar-05, Volume: 69, Issue:2-3

    Topics: Animals; Bucladesine; Cell Division; Cells, Cultured; Colforsin; Cyclic AMP; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Estradiol; Female; Guinea Pigs; Kinetics; Protein Kinase C; Receptors, Progesterone; Tamoxifen; Tetradecanoylphorbol Acetate; Uterus

1990
Identification of a hormone-responsive promoter immediately upstream of exon 1c in the human vitamin D receptor gene.
    Endocrinology, 2000, Volume: 141, Issue:8

    Topics: Base Sequence; Binding Sites; Breast Neoplasms; Cholecalciferol; Colforsin; Estradiol; Estrogen Antagonists; Estrogens; Exons; Gene Expression Regulation; Hormones; Humans; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Calcitriol; Response Elements; Tamoxifen; TATA Box; Transcription Factors; Transfection; Tretinoin; Tumor Cells, Cultured

2000
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Adenylyl Cyclases; Animals; Binding, Competitive; Breast Neoplasms; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanols; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Isomerism; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Selective Estrogen Receptor Modulators; Tamoxifen

2016